EC
KLRS
EcoR1 Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-201,718
| Closed | -$1.62M | – | 50 |
|
|
2025
Q1 | $1.62M | Sell |
201,718
-206,970
| -51% | -$1.66M | 0.1% | 38 |
|
|
2024
Q4 | $3.95M | Sell |
408,688
-10,885,897
| -96% | -$105M | 0.15% | 44 |
|
|
2024
Q3 | $9.13M | Hold |
11,294,585
| – | – | 0.31% | 43 |
|
|
2024
Q2 | $8.17M | Hold |
11,294,585
| – | – | 0.25% | 43 |
|
|
2024
Q1 | $8.53M | Buy |
+11,294,585
| New | +$8.53M | 0.22% | 44 |
|
|
2021
Q3 | – | Sell |
-447,012
| Closed | -$8.82M | – | 76 |
|
|
2021
Q2 | $8.82M | Hold |
447,012
| – | – | 0.33% | 37 |
|
|
2021
Q1 | $10.5M | Hold |
447,012
| – | – | 0.46% | 30 |
|
|
2020
Q4 | $17.2M | Hold |
447,012
| – | – | 0.92% | 22 |
|
|
2020
Q3 | $12.3M | Buy |
+447,012
| New | +$12.3M | 0.88% | 22 |
|